Facebook tracking pixel

Coming Soon

S10.AI's Next-Generation Telehealth Platform

D72.820
ICD-10-CM
Lymphocytosis

Understanding lymphocytosis: Explore its diagnosis, causes, and treatment. Find information on absolute lymphocyte count, reactive lymphocytosis, lymphocytic leukemia, viral infections, and bacterial infections as they relate to elevated lymphocyte levels. Learn about clinical documentation best practices, medical coding guidelines, and healthcare resources for managing lymphocytosis. This resource covers differential diagnosis, symptoms, and blood test interpretation relevant to high lymphocyte counts.

Also known as

Elevated lymphocyte count
High lymphocyte count

Diagnosis Snapshot

Key Facts
  • Definition : High lymphocyte count in the blood.
  • Clinical Signs : Often asymptomatic. May include swollen lymph nodes, fatigue, fever, or infection.
  • Common Settings : Infections (viral, bacterial), autoimmune disorders, blood cancers.

Related ICD-10 Code Ranges

Complete code families applicable to AAPC D72.820 Coding
R70-R79

Abnormalities of white blood cell morphology

Includes various abnormalities of white blood cells, like lymphocytosis.

D72-D72

Other disorders of white blood cells

Encompasses other white blood cell disorders not classified elsewhere.

R50-R69

General symptoms and signs

May include signs and symptoms associated with lymphocytosis, like lymphadenopathy.

Code-Specific Guidance

Decision Tree for

Follow this step-by-step guide to choose the correct ICD-10 code.

Is lymphocytosis due to a drug or other external agent?

Code Comparison

Related Codes Comparison

When to use each related code

Description
High lymphocyte count
Infectious Mononucleosis
Chronic Lymphocytic Leukemia (CLL)

Documentation Best Practices

Documentation Checklist
  • Lymphocyte count value with units
  • Confirmation of lymphocytosis (absolute count >4000/µL in adults)
  • Symptoms related to lymphocytosis documented
  • Differential diagnosis considerations included
  • Underlying cause investigation described (if identified)

Coding and Audit Risks

Common Risks
  • Unspecified Lymphocytosis

    Coding lymphocytosis without specifying reactive vs. neoplastic can lead to inaccurate severity and reimbursement.

  • Missed Underlying Cause

    Failing to code the underlying cause of lymphocytosis (e.g., infection) impacts data analysis and quality metrics.

  • Clinical Documentation Gap

    Insufficient documentation of lymphocytosis characteristics (absolute count, morphology) hinders accurate code assignment.

Mitigation Tips

Best Practices
  • Document lymphocyte subtype for accurate ICD-10 coding (C91.1).
  • Correlate lymphocytosis with clinical findings for CDI and HCC compliance.
  • Review medication list for drug-induced lymphocytosis; code adverse effects.
  • Investigate reactive causes and document etiology for improved HCC risk adjustment.
  • Ensure complete blood count with differential is coded for proper reimbursement.

Clinical Decision Support

Checklist
  • Verify absolute lymphocyte count >4000/mcL (adult)
  • Review patient medications (steroids, etc.)
  • Assess for signs/symptoms (fatigue, lymphadenopathy)
  • Consider infectious mononucleosis, lymphocytic leukemia

Reimbursement and Quality Metrics

Impact Summary
  • Lymphocytosis diagnosis coding impacts reimbursement through accurate ICD-10-CM code assignment (e.g., D72.820, R78.81) for appropriate DRG assignment and payment.
  • Coding quality metrics like Case Mix Index (CMI) and severity of illness (SOI) are affected by correct Lymphocytosis coding, influencing hospital reimbursement and performance reporting.
  • Accurate Lymphocytosis documentation and coding are crucial for quality reporting programs like PQRS and value-based purchasing, impacting hospital reimbursement and public ratings.
  • Medical billing and coding audits focusing on Lymphocytosis can identify coding errors and prevent claim denials, optimizing revenue cycle management and hospital financial performance.

Streamline Your Medical Coding

Let S10.AI help you select the most accurate ICD-10 codes. Our AI-powered assistant ensures compliance and reduces coding errors.

Frequently Asked Questions

Common Questions and Answers

Q: What is the most effective differential diagnosis approach for persistent lymphocytosis in an adult patient, considering both reactive and malignant causes?

A: A systematic approach to diagnosing persistent lymphocytosis in adults requires considering both reactive and malignant etiologies. Start with a thorough history and physical exam, paying close attention to symptoms like lymphadenopathy, splenomegaly, or B symptoms (fever, night sweats, weight loss). Initial lab work should include a complete blood count with differential, peripheral blood smear review to assess lymphocyte morphology, and metabolic panel. If the lymphocyte morphology is atypical, flow cytometry immunophenotyping is crucial to differentiate between B-cell, T-cell, and NK-cell lineages, helping pinpoint potential malignancies like chronic lymphocytic leukemia (CLL) or lymphoma. For reactive lymphocytosis, consider infectious causes like Epstein-Barr virus (EBV) or cytomegalovirus (CMV), and assess for autoimmune diseases. Further investigations, such as bone marrow biopsy or lymph node biopsy, might be necessary depending on the clinical picture and initial findings. Explore how integrating clinical findings with advanced laboratory testing improves diagnostic accuracy in persistent lymphocytosis.

Q: When should I refer a patient with absolute lymphocytosis to hematology-oncology, and what specific criteria should trigger urgent referral?

A: Referral to hematology-oncology is warranted for patients with absolute lymphocytosis when there is suspicion of malignancy, atypical lymphocyte morphology on peripheral smear, or significant lymphadenopathy or splenomegaly. Urgent referral is indicated if the patient presents with rapidly increasing lymphocyte counts, severe cytopenias (e.g., anemia, thrombocytopenia), B symptoms (fever, night sweats, weight loss), or evidence of organ dysfunction related to lymphoproliferative disorder. Suspicion of acute leukemia, aggressive lymphoma, or other rapidly progressive hematologic malignancies necessitates immediate evaluation. Additionally, consider implementing a clear referral pathway based on specific criteria, such as the presence of specific immunophenotypes identified by flow cytometry, to streamline the management of patients with lymphocytosis. Learn more about evidence-based guidelines for referral in lymphocytosis.

Quick Tips

Practical Coding Tips
  • Code underlying cause, not just lymphocytosis
  • Document lymphocyte count and morphology
  • Specify reactive vs. clonal lymphocytosis
  • Consider D72.8 for unspecified lymphocytosis
  • Check SNOMED CT for lymphoid leukemia

Documentation Templates

Patient presents with lymphocytosis, defined as an absolute lymphocyte count greater than the age-adjusted upper limit of normal.  Differential diagnosis for elevated lymphocytes includes reactive lymphocytosis secondary to infection (viral, bacterial, or parasitic), inflammatory conditions,  medications, stress,  or malignancy such as chronic lymphocytic leukemia (CLL), acute lymphoblastic leukemia (ALL), or lymphoma.  Patient's current symptoms include (list presenting symptoms e.g., fatigue, lymphadenopathy, splenomegaly, fever, weight loss, night sweats).  Physical examination findings include (document relevant findings e.g., palpable lymph nodes, splenomegaly, hepatomegaly).  Complete blood count (CBC) reveals an absolute lymphocyte count of (insert value) x 10^9L.  Peripheral blood smear review shows (describe morphology of lymphocytes e.g., atypical lymphocytes, smudge cells).  Further investigations to determine the etiology of lymphocytosis may include  viral studies (e.g., Epstein-Barr virus, cytomegalovirus, HIV),  flow cytometry, bone marrow biopsy, and lymph node biopsy if clinically indicated.  Initial management plan includes (outline plan e.g.,  monitoring, further workup for underlying cause, referral to hematologyoncology).  Patient education provided regarding lymphocytosis causes, diagnostic testing, and potential treatment options. Follow-up scheduled for (date) to review results and discuss further management.  ICD-10 code D72.829 (Other specified lymphocytosis) may be applicable, pending confirmation of the underlying etiology.  Medical coding and billing will reflect the complexity of the evaluation and management.
Lymphocytosis - AI-Powered ICD-10 Documentation